Retour

STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split

Stocks Changes in company's own shares

HORSHAM, Penn., April 26, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10 that will become effective at 11:59 p.m. Eastern Time on June 6, 2024. The Company’s common stock will begin trading on Nasdaq on a split-adjusted basis when the market opens on June 7, 2024 under the existing symbol, SSKN, and under a new CUSIP number, 86272A 305. This reverse stock split is primarily intended to bring the Company into compliance with Nasdaq’s minimum bid price requirement for continued listing.

GlobeNewswire Inc. • 26/04/2024 à 23:20:00
Strata Skin Sciences, Inc. Common Stock
Address: 5 WALNUT GROVE DRIVE
Postal Code: 19044
City: HORSHAM
State: PA
Phone Number: 215-619-3200
Website: https://www.strataskinsciences.com
Status: Active
Company Info

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

List Date2005-10-28
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001051514
Composite figiBBG000DK7609
Share Class figiBBG001SHBV08
Market Cap14,623,910 USD
SIC Code3841
SIC DescriptionSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Total Employees99
Share Class Shares Outstanding35060000
Weighted Shares Outstanding35060920
Round Lot100
Updated date2024-05-05
Stats
Last 5 days
7-05
6-05
3-05
2-05
1-05
Last
0.425
0.425
0.428
0.405
0.431
Variance
5.46%
0%
4.9%
-4.71%
0.23%
Open
0.403
0.425
0.408
0.425
0.43
Highest
0.432
0.438
0.432
0.434
0.435
Lowest
0.432
0.438
0.43
0.434
0.435
History
PeriodVarhighestlowest
1 week
-1.16%
0.435
0.425
1 month
-12.01%
0.749
0.425
3 month
-21.31%
0.589
0.425
6 month
-6.59%
0.455
0.262
1 year
-57.5%
1.0538
0.262
3 year
-73.44%
1.625
0.262
5 year
-83.96%
2.67
0.262
10 year
-92.74%
5.9
0.262
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-09 2023-11-14 UNPUB
Assets 49,123,000 55,204,000 47,193,000 UNPUB
Current Assets 14,512,000 21,245,000 19,722,000 UNPUB
Current Liabilities 13,058,000 14,120,000 12,025,000 UNPUB
Equity 19,321,000 16,909,000 16,193,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 19,321,000 16,909,000 16,193,000 UNPUB
Liabilities 29,802,000 38,295,000 31,000,000 UNPUB
Liabilities And Equity 49,123,000 55,204,000 47,193,000 UNPUB
Noncurrent Assets 34,611,000 33,959,000 27,471,000 UNPUB
Noncurrent Liabilities 16,744,000 24,175,000 18,975,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-09 2023-11-14 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 3,600,000 -1,930,000 UNPUB
Net Cash Flow, Continuing 0 3,600,000 -1,930,000 UNPUB
Net Cash Flow From Financing Activities 2,609,000 4,356,000 -104,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 2,609,000 4,356,000 -104,000 UNPUB
Net Cash Flow From Investing Activities -1,406,000 -931,000 -829,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -1,406,000 -931,000 -829,000 UNPUB
Net Cash Flow From Operating Activities -1,203,000 175,000 -997,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -1,203,000 175,000 -997,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-09 2023-11-14 UNPUB
Comprehensive Income/Loss -2,835,000 -3,148,000 -1,053,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -2,835,000 -3,148,000 -1,053,000 UNPUB
Other Comprehensive Income/Loss 0 0 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-09 2023-11-14 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 6,974,000 6,280,000 5,569,000 UNPUB
Cost Of Revenue 3,179,000 3,932,000 3,898,000 UNPUB
Costs And Expenses 6,974,000 6,280,000 5,569,000 UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit 4,388,000 4,318,000 4,954,000 UNPUB
Income/Loss From Continuing Operations After Tax -2,835,000 -3,148,000 -1,053,000 UNPUB
Income/Loss From Continuing Operations Before Tax 593,000 1,970,000 3,283,000 UNPUB
Income Tax Expense/Benefit 0 0 0 UNPUB
Interest Expense, Operating 286,000 298,000 528,000 UNPUB
Net Income/Loss -2,835,000 -3,148,000 -1,053,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -2,835,000 -3,148,000 -1,053,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -2,835,000 -3,148,000 -1,053,000 UNPUB
Operating Expenses 6,974,000 6,280,000 5,569,000 UNPUB
Operating Income/Loss -2,586,000 -1,962,000 -615,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 7,567,000 8,250,000 8,852,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-11 2022-08-10 2022-11-09 2023-03-31
Assets 55,087,000 53,587,000 53,235,000 52,272,000
Current Assets 19,046,000 18,628,000 18,753,000 17,504,000
Current Liabilities 14,419,000 14,362,000 14,158,000 13,426,000
Equity 23,780,000 22,340,000 21,800,000 21,831,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 23,780,000 22,340,000 21,800,000 21,831,000
Liabilities 31,307,000 31,247,000 31,435,000 30,441,000
Liabilities And Equity 55,087,000 53,587,000 53,235,000 52,272,000
Noncurrent Assets 36,041,000 34,959,000 34,482,000 34,768,000
Noncurrent Liabilities 0 0 17,277,000 17,015,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-11 2022-08-10 2022-11-09 2023-03-31
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 -5,791,000
Net Cash Flow, Continuing 0 0 0 -5,791,000
Net Cash Flow From Financing Activities 1,663,000 887,000 1,221,000 -500,000
Net Cash Flow From Financing Activities, Continuing 1,663,000 887,000 1,221,000 -500,000
Net Cash Flow From Investing Activities -1,310,000 -831,000 -527,000 -4,183,000
Net Cash Flow From Investing Activities, Continuing -1,310,000 -831,000 -527,000 -4,183,000
Net Cash Flow From Operating Activities -353,000 -56,000 -694,000 -1,108,000
Net Cash Flow From Operating Activities, Continuing -353,000 -56,000 -694,000 -1,108,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-11 2022-08-10 2022-11-09 2023-03-31
Comprehensive Income/Loss -2,502,000 -1,892,000 -995,000 -5,549,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,502,000 -1,892,000 -995,000 -5,549,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-11 2022-08-10 2022-11-09 2023-03-31
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 9,543,000 10,997,000 10,408,000 41,647,000
Cost Of Revenue 2,913,000 4,112,000 3,614,000 14,393,000
Costs And Expenses 6,431,000 6,687,000 6,585,000 26,417,000
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit 4,128,000 4,993,000 5,799,000 21,768,000
Income/Loss From Continuing Operations After Tax -2,502,000 -1,892,000 -995,000 -5,549,000
Income/Loss From Continuing Operations Before Tax -2,502,000 -1,892,000 -995,000 -5,486,000
Income Tax Expense/Benefit 0 0 0 63,000
Interest Expense, Operating 199,000 208,000 244,000 926,000
Net Income/Loss -2,502,000 -1,892,000 -995,000 -5,549,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,502,000 -1,892,000 -995,000 -5,549,000
Net Income/Loss Available To Common Stockholders, Basic -2,502,000 -1,892,000 -995,000 -5,549,000
Operating Expenses 6,431,000 6,687,000 6,585,000 26,417,000
Operating Income/Loss -2,303,000 -1,694,000 -786,000 -4,649,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 7,041,000 9,105,000 9,413,000 36,161,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-16 2021-11-12 2022-03-21
Assets 45,854,000 44,899,000 46,758,000 46,593,000
Current Assets 24,103,000 23,462,000 20,046,000 19,970,000
Current Liabilities 20,106,000 17,779,000 12,154,000 12,802,000
Equity 24,136,000 25,799,000 26,183,000 25,414,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 24,136,000 25,799,000 26,183,000 25,414,000
Liabilities 21,718,000 19,100,000 20,575,000 21,179,000
Liabilities And Equity 45,854,000 44,899,000 46,758,000 46,593,000
Noncurrent Assets 21,751,000 21,437,000 26,712,000 26,623,000
Noncurrent Liabilities 0 0 8,421,000 8,377,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-16 2021-11-12 2022-03-21
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 -5,065,000 -5,526,000
Net Cash Flow, Continuing 0 0 -5,065,000 -5,526,000
Net Cash Flow From Financing Activities 587,000 492,000 -987,000 92,000
Net Cash Flow From Financing Activities, Continuing 587,000 492,000 -987,000 92,000
Net Cash Flow From Investing Activities -740,000 -726,000 -4,530,000 -7,126,000
Net Cash Flow From Investing Activities, Continuing -740,000 -726,000 -4,530,000 -7,126,000
Net Cash Flow From Operating Activities 153,000 234,000 452,000 1,508,000
Net Cash Flow From Operating Activities, Continuing 153,000 234,000 452,000 1,508,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-16 2021-11-12 2022-03-21
Comprehensive Income/Loss -2,418,000 1,082,000 -521,000 -2,706,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,418,000 1,082,000 -521,000 -2,706,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-16 2021-11-12 2022-03-21
Basic Earnings Per Share 0 0 UNPUB UNPUB
Benefits Costs and Expenses 8,241,000 6,296,000 8,228,000 32,649,000
Cost Of Revenue 2,114,000 2,621,000 2,335,000 10,127,000
Costs And Expenses 8,241,000 6,296,000 8,228,000 32,649,000
Diluted Earnings Per Share 0 0 UNPUB UNPUB
Gross Profit 3,713,000 4,761,000 5,376,000 19,850,000
Income/Loss From Continuing Operations After Tax -2,418,000 1,082,000 -521,000 -2,706,000
Income/Loss From Continuing Operations Before Tax -2,414,000 1,086,000 -517,000 -2,672,000
Income Tax Expense/Benefit 4,000 4,000 4,000 34,000
Interest Expense, Operating UNPUB UNPUB UNPUB 314,000
Net Income/Loss -2,418,000 1,082,000 -521,000 -2,706,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,418,000 1,082,000 -521,000 -2,706,000
Net Income/Loss Available To Common Stockholders, Basic -2,418,000 1,082,000 -521,000 -2,706,000
Operating Expenses 6,105,000 5,684,000 5,841,000 24,252,000
Operating Income/Loss -2,392,000 -923,000 -465,000 -4,402,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 5,827,000 7,382,000 7,711,000 29,977,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-12 2020-11-10 2021-03-25
Assets 46,047,000 46,210,000 47,064,000 46,778,000
Current Assets 22,797,000 23,889,000 24,936,000 24,831,000
Current Liabilities 16,804,000 16,601,000 18,680,000 18,838,000
Equity 28,048,000 26,778,000 25,927,000 25,892,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 28,048,000 26,778,000 25,927,000 25,892,000
Liabilities 17,999,000 19,432,000 21,137,000 20,886,000
Liabilities And Equity 46,047,000 46,210,000 47,064,000 46,778,000
Noncurrent Assets 23,250,000 22,321,000 22,128,000 21,947,000
Noncurrent Liabilities 0 0 2,457,000 2,048,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-12 2020-11-10 2021-03-25
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 2,999,000 -168,000 2,483,000
Net Cash Flow, Continuing 0 2,999,000 -168,000 2,483,000
Net Cash Flow From Financing Activities -2,000 2,530,000 0 2,546,000
Net Cash Flow From Financing Activities, Continuing -2,000 2,530,000 0 2,546,000
Net Cash Flow From Investing Activities -596,000 -134,000 -717,000 -2,159,000
Net Cash Flow From Investing Activities, Continuing -596,000 -134,000 -717,000 -2,159,000
Net Cash Flow From Operating Activities 598,000 603,000 549,000 2,096,000
Net Cash Flow From Operating Activities, Continuing 598,000 603,000 549,000 2,096,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-12 2020-11-10 2021-03-25
Comprehensive Income/Loss -1,035,000 -1,680,000 -1,254,000 -4,412,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,035,000 -1,680,000 -1,254,000 -4,412,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-12 2020-11-10 2021-03-25
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 7,677,000 5,663,000 6,795,000 27,227,000
Cost Of Revenue 2,331,000 2,066,000 2,383,000 8,956,000
Costs And Expenses 7,677,000 5,663,000 6,795,000 27,227,000
Diluted Earnings Per Share 0 0 0 0
Gross Profit 4,399,000 1,964,000 3,230,000 14,134,000
Income/Loss From Continuing Operations After Tax -1,035,000 -1,680,000 -1,254,000 -4,412,000
Income/Loss From Continuing Operations Before Tax -947,000 -1,633,000 -1,182,000 -4,137,000
Income Tax Expense/Benefit 88,000 47,000 72,000 275,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -1,035,000 -1,680,000 -1,254,000 -4,412,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,035,000 -1,680,000 -1,254,000 -4,412,000
Net Income/Loss Available To Common Stockholders, Basic -1,018,000 -1,680,000 -1,254,000 -4,412,000
Operating Expenses 5,347,000 3,579,000 4,391,000 18,210,000
Operating Income/Loss -948,000 -1,615,000 -1,161,000 -4,076,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 6,730,000 4,030,000 5,613,000 23,090,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-11-08 2019-11-14 2019-11-18 2020-03-17
Assets 47,739,000 47,967,000 47,517,000 47,343,000
Current Assets 23,515,000 23,654,000 23,984,000 23,555,000
Current Liabilities 10,135,000 11,137,000 12,189,000 17,434,000
Equity 30,238,000 29,459,000 28,856,000 28,653,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 30,238,000 29,459,000 28,856,000 28,653,000
Liabilities 17,501,000 18,508,000 18,661,000 18,690,000
Liabilities And Equity 47,739,000 47,967,000 47,517,000 47,343,000
Noncurrent Assets 24,224,000 24,313,000 23,533,000 23,788,000
Noncurrent Liabilities 0 0 6,472,000 1,256,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-11-08 2019-11-14 2019-11-18 2020-03-17
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -98,000 98,000 0 -858,000
Net Cash Flow, Continuing -98,000 98,000 0 -858,000
Net Cash Flow From Financing Activities 0 546,000 -287,000 -296,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB -287,000 -296,000
Net Cash Flow From Investing Activities -434,000 -518,000 -423,000 -2,791,000
Net Cash Flow From Investing Activities, Continuing -434,000 -518,000 -423,000 -2,791,000
Net Cash Flow From Operating Activities 336,000 70,000 710,000 2,229,000
Net Cash Flow From Operating Activities, Continuing 336,000 70,000 710,000 2,229,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-11-08 2019-11-14 2019-11-18 2020-03-17
Comprehensive Income/Loss -1,333,000 -1,082,000 -860,000 -3,790,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,333,000 -1,082,000 -860,000 -3,790,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-11-08 2019-11-14 2019-11-18 2020-03-17
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 8,859,000 8,853,000 8,362,000 35,525,000
Cost Of Revenue 2,874,000 2,815,000 2,855,000 11,316,000
Costs And Expenses 8,859,000 8,853,000 8,362,000 35,525,000
Diluted Earnings Per Share 0 0 0 0
Gross Profit 4,609,000 4,910,000 4,625,000 20,270,000
Income/Loss From Continuing Operations After Tax -1,333,000 -1,082,000 -860,000 -3,790,000
Income/Loss From Continuing Operations Before Tax -1,376,000 -1,128,000 -882,000 -3,939,000
Income Tax Expense/Benefit -43,000 -46,000 -22,000 -149,000
Interest Expense, Operating 135,000 145,000 153,000 515,000
Net Income/Loss -1,333,000 -1,082,000 -860,000 -3,790,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,333,000 -1,082,000 -860,000 -3,790,000
Net Income/Loss Available To Common Stockholders, Basic -1,216,000 -1,007,000 -840,000 -3,597,000
Operating Expenses 5,850,000 5,893,000 5,354,000 23,280,000
Operating Income/Loss -1,241,000 -983,000 -729,000 -3,010,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 -20,000 -193,000
Preferred Stock Dividends And Other Adjustments 0 0 -20,000 -193,000
Revenues 7,483,000 7,725,000 7,480,000 31,586,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-15 2018-08-14 UNPUB 2019-10-30
Assets 37,205,000 46,052,000 UNPUB 47,507,000
Current Assets 10,316,000 20,260,000 UNPUB 23,210,000
Current Liabilities 11,586,000 7,084,000 UNPUB 8,615,000
Equity 17,623,000 30,603,000 UNPUB 31,248,000
Equity Attributable To Noncontrolling Interest 0 0 UNPUB 0
Equity Attributable To Parent 17,623,000 30,603,000 UNPUB 31,248,000
Liabilities 19,582,000 15,449,000 UNPUB 16,259,000
Liabilities And Equity 37,205,000 46,052,000 UNPUB 47,507,000
Noncurrent Assets 26,889,000 25,792,000 UNPUB 24,297,000
Noncurrent Liabilities 7,996,000 8,365,000 UNPUB 7,644,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-15 2018-08-14 UNPUB 2019-10-30
Exchange Gains/Losses 0 0 UNPUB 0
Net Cash Flow -652,000 11,028,000 UNPUB 12,418,000
Net Cash Flow, Continuing -652,000 11,028,000 UNPUB 12,418,000
Net Cash Flow From Financing Activities -307,000 11,665,000 UNPUB 11,307,000
Net Cash Flow From Financing Activities, Continuing -307,000 11,665,000 UNPUB 11,307,000
Net Cash Flow From Investing Activities -405,000 -509,000 UNPUB -1,785,000
Net Cash Flow From Investing Activities, Continuing -405,000 -509,000 UNPUB -1,785,000
Net Cash Flow From Operating Activities 60,000 -128,000 UNPUB 2,896,000
Net Cash Flow From Operating Activities, Continuing 60,000 -128,000 UNPUB 2,896,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-15 2018-08-14 UNPUB 2019-10-30
Comprehensive Income/Loss -2,042,000 -1,868,000 UNPUB -4,033,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 UNPUB 0
Comprehensive Income/Loss Attributable To Parent -2,042,000 -1,868,000 UNPUB -4,033,000
Other Comprehensive Income/Loss 0 0 UNPUB -4,033,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-15 2018-08-14 UNPUB 2019-10-30
Basic Earnings Per Share 0 0 UNPUB 0
Benefits Costs and Expenses 8,740,000 9,216,000 UNPUB 34,152,000
Cost Of Revenue 3,345,000 3,549,000 UNPUB 12,735,000
Costs And Expenses 8,740,000 9,216,000 UNPUB 34,152,000
Diluted Earnings Per Share 0 0 UNPUB 0
Gross Profit 3,393,000 3,839,000 UNPUB 17,120,000
Income/Loss From Continuing Operations After Tax -2,042,000 -1,868,000 UNPUB -4,033,000
Income/Loss From Continuing Operations Before Tax -2,002,000 -1,828,000 UNPUB -4,297,000
Income Tax Expense/Benefit 40,000 40,000 UNPUB -264,000
Interest Expense, Operating 363,000 328,000 UNPUB 1,142,000
Net Income/Loss -2,042,000 -1,868,000 UNPUB -4,033,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 UNPUB 0
Net Income/Loss Attributable To Parent -2,042,000 -1,868,000 UNPUB -4,033,000
Net Income/Loss Available To Common Stockholders, Basic -504,000 -1,099,000 UNPUB -2,909,000
Operating Expenses 5,093,000 5,058,000 UNPUB 20,475,000
Operating Income/Loss -1,700,000 -1,219,000 UNPUB -3,355,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic -1,538,000 -769,000 UNPUB -1,124,000
Preferred Stock Dividends And Other Adjustments -1,538,000 -769,000 UNPUB -1,124,000
Revenues 6,738,000 7,388,000 UNPUB 29,855,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-15 2017-08-11 2017-11-14 2018-04-02
Assets 43,207,000 42,902,000 39,864,000 38,631,000
Current Assets 10,525,000 11,358,000 10,053,000 10,752,000
Current Liabilities 7,564,000 8,440,000 6,126,000 7,672,000
Equity 12,592,000 11,614,000 23,917,000 22,245,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 12,592,000 11,614,000 23,917,000 22,245,000
Liabilities 30,615,000 31,288,000 15,947,000 16,386,000
Liabilities And Equity 43,207,000 42,902,000 39,864,000 38,631,000
Noncurrent Assets 32,682,000 31,544,000 29,811,000 27,879,000
Noncurrent Liabilities 23,051,000 22,848,000 9,821,000 8,714,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-15 2017-08-11 2017-11-14 2018-04-02
Exchange Gains/Losses UNPUB UNPUB 0 -2,000
Net Cash Flow -165,000 175,000 -811,000 141,000
Net Cash Flow, Continuing -165,000 175,000 -811,000 143,000
Net Cash Flow From Financing Activities -100,000 -101,000 -960,000 -1,803,000
Net Cash Flow From Financing Activities, Continuing -100,000 -101,000 -960,000 -1,803,000
Net Cash Flow From Investing Activities -883,000 -603,000 -400,000 -2,194,000
Net Cash Flow From Investing Activities, Continuing -883,000 -603,000 -400,000 -2,194,000
Net Cash Flow From Operating Activities 818,000 879,000 549,000 4,140,000
Net Cash Flow From Operating Activities, Continuing 818,000 879,000 549,000 4,140,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-15 2017-08-11 2017-11-14 2018-04-02
Comprehensive Income/Loss -2,235,000 -1,205,000 -13,671,000 -18,833,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,235,000 -1,205,000 -13,671,000 -18,833,000
Other Comprehensive Income/Loss 0 0 -13,671,000 -18,833,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -2,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-15 2017-08-11 2017-11-14 2018-04-02
Basic Earnings Per Share -1 -1 -4 -3
Benefits Costs and Expenses 9,437,000 9,834,000 21,113,000 50,151,000
Cost Of Revenue 2,733,000 3,173,000 3,276,000 13,498,000
Costs And Expenses 9,437,000 9,834,000 21,113,000 50,151,000
Diluted Earnings Per Share -1 -1 -4 -3
Gross Profit 4,539,000 5,529,000 4,204,000 17,951,000
Income/Loss From Continuing Operations After Tax -2,235,000 -1,205,000 -13,671,000 -18,831,000
Income/Loss From Continuing Operations Before Tax -2,165,000 -1,132,000 -13,633,000 -18,702,000
Income Tax Expense/Benefit 70,000 73,000 38,000 129,000
Interest Expense, Operating 1,346,000 1,575,000 1,343,000 4,612,000
Net Income/Loss -2,235,000 -1,205,000 -13,671,000 -18,831,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,235,000 -1,205,000 -13,671,000 -18,831,000
Net Income/Loss Available To Common Stockholders, Basic -2,235,000 -1,205,000 -13,671,000 -18,831,000
Operating Expenses 5,226,000 5,220,000 4,776,000 20,361,000
Operating Income/Loss -687,000 309,000 -572,000 -2,410,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 7,272,000 8,702,000 7,480,000 31,449,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-16 2016-08-12 2016-11-14 2017-03-13
Assets 47,509,000 44,406,000 42,950,000 43,193,000
Current Assets 10,896,000 9,555,000 9,388,000 10,752,000
Current Liabilities 5,562,000 4,394,000 4,621,000 6,133,000
Equity 15,032,000 17,272,000 15,877,000 14,719,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 15,032,000 17,272,000 15,877,000 14,719,000
Liabilities 32,477,000 27,134,000 27,073,000 28,474,000
Liabilities And Equity 47,509,000 44,406,000 42,950,000 43,193,000
Noncurrent Assets 36,613,000 34,851,000 33,562,000 32,441,000
Noncurrent Liabilities 26,915,000 22,740,000 22,452,000 22,341,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-16 2016-08-12 2016-11-14 2017-03-13
Exchange Gains/Losses UNPUB UNPUB -3,000 4,000
Net Cash Flow -183,000 -279,000 116,000 625,000
Net Cash Flow, Continuing -183,000 -286,000 119,000 621,000
Net Cash Flow From Financing Activities 1,395,000 -102,000 -92,000 1,167,000
Net Cash Flow From Financing Activities, Continuing 1,395,000 -102,000 -92,000 1,167,000
Net Cash Flow From Investing Activities -182,000 -6,000 -279,000 -868,000
Net Cash Flow From Investing Activities, Continuing -182,000 -6,000 -279,000 -868,000
Net Cash Flow From Operating Activities -1,396,000 -178,000 490,000 322,000
Net Cash Flow From Operating Activities, Continuing -1,396,000 -178,000 490,000 322,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-16 2016-08-12 2016-11-14 2017-03-13
Comprehensive Income/Loss -1,437,000 500,000 -1,510,000 -3,334,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,437,000 500,000 -1,510,000 -3,334,000
Other Comprehensive Income/Loss 0 500,000 -1,510,000 -3,334,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-16 2016-08-12 2016-11-14 2017-03-13
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 8,991,000 7,180,000 9,212,000 34,837,000
Cost Of Revenue 3,422,000 3,139,000 3,070,000 12,636,000
Costs And Expenses 8,991,000 7,180,000 9,212,000 34,837,000
Diluted Earnings Per Share 0 0 0 -1
Gross Profit 4,198,000 4,600,000 4,697,000 19,121,000
Income/Loss From Continuing Operations After Tax -1,437,000 498,000 -1,509,000 -3,335,000
Income/Loss From Continuing Operations Before Tax -1,371,000 559,000 -1,445,000 -3,080,000
Income Tax Expense/Benefit 66,000 61,000 64,000 255,000
Interest Expense, Operating 1,218,000 1,178,000 1,175,000 4,900,000
Net Income/Loss -1,437,000 498,000 -1,509,000 -3,335,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,437,000 498,000 -1,509,000 -3,335,000
Net Income/Loss Available To Common Stockholders, Basic -1,437,000 498,000 -1,509,000 -3,335,000
Operating Expenses 6,336,000 6,058,000 5,102,000 22,718,000
Operating Income/Loss -2,138,000 -1,458,000 -405,000 -3,597,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 7,620,000 7,739,000 7,767,000 31,757,000
Calendar
8 May 2024 (Time UTC) Actual Previous Consensus
★
13:30
United States
★
13:00
United States
4.483
4.560
★
12:00
United States
★
11:45
United States
★
11:00
United States
★
11:00
United States
MAY
53.440
★
10:30
United States
MAY 03
915000.000
344000.000
-1180000.000
★
10:30
United States
MAY 03
1.000
-1.000
★
10:30
United States
MAY 03
285000.000
-179000.000
★
10:30
United States
MAY 03
99000.000
254000.000
★
10:30
United States
MAY 03
560000.000
-732000.000
-1000000.000
★
10:30
United States
275000.000
-271000.000
★★
10:30
United States
MAY 03
1880000.000
1089000.000
★
10:30
United States
MAY 03
-353000.000
1536000.000
★
10:30
United States
MAY 03
307000.000
-230000.000
News Stream
News Conference Calls/ Webcasts
STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update
HORSHAM, Penn., May 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2024 financial results on Wednesday, May 15, 2024 after the market close.
GlobeNewswire Inc. • 10h ago
Management Management statements
STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024
HORSHAM, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the placement of six XTRAC® devices with dermatology clinics in the first quarter of 2024 that are considered “comebacks.” Comebacks are excimer placements with dermatology clinics that were previously active in the Company’s partner program, then terminated their relationship with the Company at some point in the past but have now decided to return to STRATA under the partner program. Among these comebacks are Henry Ford Health System in Detroit, Integrated Dermatology Group, and several practices from the Schweiger Dermatology Group.
GlobeNewswire Inc. • 1w ago
Stocks Changes in company's own shares
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
HORSHAM, Penn., April 26, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10 that will become effective at 11:59 p.m. Eastern Time on June 6, 2024. The Company’s common stock will begin trading on Nasdaq on a split-adjusted basis when the market opens on June 7, 2024 under the existing symbol, SSKN, and under a new CUSIP number, 86272A 305. This reverse stock split is primarily intended to bring the Company into compliance with Nasdaq’s minimum bid price requirement for continued listing.
GlobeNewswire Inc. • 1w ago
Calendar Calendar of Events
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas.
GlobeNewswire Inc. • 2w ago
Stocks Business Contracts
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
Distributors in China and Japan have each maintained exclusive distribution agreements with the Company for over 10 years and collectively accounted for 46% of the Company’s total international revenue in 2023 Distributors in China and Japan have each maintained exclusive distribution agreements with the Company for over 10 years and collectively accounted for 46% of the Company’s total international revenue in 2023
GlobeNewswire Inc. • 4w ago
stocks Earnings Releases and Operating Results
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET
GlobeNewswire Inc. • 1mo ago
Stocks Earnings Releases and Operating Results
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET
GlobeNewswire Inc. • 1mo ago
News Conference Calls/ Webcasts
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
HORSHAM, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it plans to release its fourth quarter and full-year 2023 financial results on Wednesday, March 27, 2024. Management will hold a conference call to review the financial results and provide a corporate update at 4:30 PM ET on the same day.
GlobeNewswire Inc. • 1mo ago
Health Health
STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
HORSHAM, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced an initiative aimed at expanding insurance coverage for essential treatments for conditions such as mycosis fungoides, lichen planus, alopecia areata, and cutaneous T-Cell lymphoma (CTCL), with an initial targeted focus on expanding coverage for vitiligo and atopic dermatitis, skin diseases effecting up to 3 and 16 million people in the United States respectively1. The Company is leveraging its extensive patient database and engaging in targeted governmental relations efforts, this initiative focuses on broadening Current Procedural Terminology (“CPT”) code coverage to increase patient access to advanced treatments and enable higher provider reimbursement rates.
GlobeNewswire Inc. • 2mo ago
Stocks Financing Agreements
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
–Amends certain financial covenants to enhance liquidity and financial flexibility– –Ensures alignment with the Company’s current and future business operations–
GlobeNewswire Inc. • 2mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT